Portolan Capital Management, LLC Anika Therapeutics, Inc. Transaction History

Portolan Capital Management, LLC

$1.26 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$25.16 - $28.86 $2.68 Million - $3.07 Million	-106,443 Reduced 49.49%	108,632 $2.82 Million
Q1 2023 May 15, 2023	BUY	$25.91 - $32.1 $185,904 - $230,317	7,175 Added 3.45%	215,075 $6.18 Million
Q4 2022 Feb 13, 2023	SELL	$23.85 - $31.91 $636,866 - $852,092	-26,703 Reduced 11.38%	207,900 $6.15 Million
Q3 2022 Nov 14, 2022	SELL	$21.74 - $24.68 $29,762 - $33,786	-1,369 Reduced 0.58%	234,603 $5.58 Million
Q2 2022 Aug 15, 2022	BUY	$20.4 - $25.53 $4.81 Million - $6.02 Million	235,972 New	235,972 $5.27 Million
Q3 2021 Nov 15, 2021	SELL	$38.75 - $44.47 $1.94 Million - $2.23 Million	-50,177 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$39.42 - $48.08 $1.98 Million - $2.41 Million	50,177 New	50,177 $2.17 Million
Q4 2020 Feb 16, 2021	SELL	$32.59 - $45.26 $251,203 - $348,864	-7,708 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$32.56 - $38.57 $68,571 - $81,228	-2,106 Reduced 21.46%	7,708 $273,000
Q2 2020 Aug 14, 2020	SELL	$27.83 - $37.73 $33,896 - $45,955	-1,218 Reduced 11.04%	9,814 $370,000
Q1 2020 May 14, 2020	SELL	$22.38 - $54.06 $76,741 - $185,371	-3,429 Reduced 23.71%	11,032 $319,000
Q3 2019 Nov 14, 2019	SELL	$40.05 - $57.47 $38,728 - $55,573	-967 Reduced 6.27%	14,461 $794,000
Q2 2019 Aug 14, 2019	BUY	$30.3 - $41.14 $23,391 - $31,760	772 Added 5.27%	15,428 $627,000
Q1 2019 May 15, 2019	SELL	$29.37 - $40.49 $3.05 Million - $4.21 Million	-103,853 Reduced 87.63%	14,656 $443,000
Q4 2018 Feb 13, 2019	SELL	$30.16 - $43.0 $388,249 - $553,539	-12,873 Reduced 9.8%	118,509 $3.98 Million
Q3 2018 Nov 14, 2018	SELL	$32.83 - $42.51 $1.01 Million - $1.3 Million	-30,698 Reduced 18.94%	131,382 $5.54 Million
Q2 2018 Aug 14, 2018	BUY	$28.77 - $48.27 $3 Million - $5.03 Million	104,148 Added 179.78%	162,080 $5.19 Million
Q1 2018 May 14, 2018	BUY	$49.22 - $68.43 $2.13 Million - $2.97 Million	43,376 Added 297.99%	57,932 $2.88 Million
Q4 2017 Feb 14, 2018	SELL	$52.14 - $59.94 $521 - $599	-10 Reduced 0.07%	14,556 $785,000
Q3 2017 Nov 14, 2017	BUY	$51.16 - $58.21 $745,196 - $847,886	14,566	14,566 $845,000

Others Institutions Holding ANIK

# of Institutions

123

Shares Held

11.5M

Call Options Held

200

Put Options Held

100

Trigran Investments, Inc.

2.12M
Shares

$34.4 Million
5.75% of portfolio
Black Rock Inc. New York, NY

1.61M
Shares

$26 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

799K
Shares

$12.9 Million
0.0% of portfolio
Dimensional Fund Advisors LP Austin, TX

707K
Shares

$11.5 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

574K
Shares

$9.3 Million
0.02% of portfolio

View Full List

About Anika Therapeutics, Inc.

Ticker ANIK
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,599,900
Market Cap $236M
Description
Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...

More about ANIK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Portolan Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Portolan Capital Management, LLC with notifications on news.

Account